Emmes Group Teams Up with Health Tech Startup Miimansa AI to Transform Clinical Research

The partnership comes at a time when artificial intelligence is poised to reshape various aspects of healthcare, including clinical research.
In a significant move set to transform the landscape of clinical research, Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has announced a multi-year strategic partnership with Miimansa AI. The collaboration, which includes the acquisition of Miimansa's Clinical Entity Modeling tools, aims to leverage advanced large language modeling (LLM) techniques and generative AI to revolutionize clinical research processes at Emmes. The partnership comes at a time when artificial intelligence is poised to reshape various aspects of healthcare, including clinical research. Emmes Group is actively enhancing its technology platform, Veridix AI, and the acquisition of Miimansa's Clinical Entity Modeling technology is expected to play a crucial role in acceler
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of Abhijeet Adhikari
Abhijeet Adhikari
Abhijeet Adhikari is a Research Associate at AIM-Research, focusing on AI and data science related research reports. Beyond his professional role, Abhijeet is an avid reader with a particular interest in historical and mythological facts, you can reach him at abhijeet.adhikari@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.